Logo image of MRX

MAREX GROUP PLC (MRX) Stock Analyst Ratings

NASDAQ:MRX - Nasdaq - GB00BMT7GT62 - Common Stock - Currency: USD

37.03  -1.78 (-4.59%)

After market: 37.03 0 (0%)

Buy % Consensus

83

ChartMill assigns a Buy % Consensus number of 83% to MRX. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 38.38. This target is 3.64% above the current price.
MRX was analyzed by 12 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about MRX.
In the previous month the buy percentage consensus was at a similar level.
MRX was analyzed by 12 analysts, which is quite many. So the average rating should be quite meaningful.
MRX Historical Analyst RatingsMRX Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -8 -7 -6 -5 -4 -3 -2 -1 0 2 4 6 8 10

Price Target & Forecast

Price Low Median Mean High 37.0333.3339.2738.3842.00 - -9.99% 6.05% 3.64% 13.42%
MRX Current Analyst RatingMRX Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6
Up and Down Grades
Date Firm Action Rating
2025-01-13 Barclays Maintains Overweight -> Overweight
2025-01-07 Piper Sandler Maintains Overweight -> Overweight
2024-12-20 Keefe, Bruyette & Woods Maintains Outperform -> Outperform
2024-12-09 Barclays Maintains Overweight -> Overweight
2024-11-21 HSBC Initiate Buy
2024-11-08 Keefe, Bruyette & Woods Maintains Outperform -> Outperform
2024-11-08 Barclays Maintains Overweight -> Overweight
2024-11-08 Piper Sandler Maintains Overweight -> Overweight
2024-11-06 Citigroup Reiterate Buy -> Buy
2024-10-07 Barclays Maintains Overweight -> Overweight
2024-08-15 Barclays Maintains Overweight -> Overweight
2024-08-15 Piper Sandler Maintains Overweight -> Overweight
2024-08-14 Piper Sandler Reiterate Overweight -> Overweight
2024-05-20 Keefe, Bruyette & Woods Initiate Outperform
2024-05-20 UBS Initiate Buy
2024-05-20 Barclays Initiate Overweight
2024-05-20 Goldman Sachs Initiate Buy
2024-05-20 Piper Sandler Initiate Overweight
2024-05-20 Citigroup Initiate Buy
2024-05-20 Jefferies Initiate Buy